Stochastic asymmetric repartition of lytic machinery in dividing CD8

cell division cytotoxic t lymphocytes human human lymphocytes immunology inflammation lysosomal-associated membrane proteins lytic granules

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
11 01 2021
Historique:
received: 02 09 2020
accepted: 08 01 2021
pubmed: 12 1 2021
medline: 4 2 2022
entrez: 11 1 2021
Statut: epublish

Résumé

Cytotoxic immune cells are endowed with a high degree of heterogeneity in their lytic function, but how this heterogeneity is generated is still an open question. We therefore investigated if human CD8

Identifiants

pubmed: 33427199
doi: 10.7554/eLife.62691
pii: 62691
pmc: PMC7867409
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021, Lafouresse et al.

Déclaration de conflit d'intérêts

FL, RJ, SM, MD, VD, EE, MP, SG, SV No competing interests declared

Références

Nat Immunol. 2017 Aug;18(8):940-950
pubmed: 28628092
Trends Biotechnol. 2018 Jul;36(7):649-652
pubmed: 29395345
Science. 2007 Mar 23;315(5819):1687-91
pubmed: 17332376
Nat Rev Mol Cell Biol. 2020 Mar;21(3):151-166
pubmed: 32034394
Nat Commun. 2016 Mar 04;7:10823
pubmed: 26940455
J Immunol Methods. 2018 Mar;454:59-70
pubmed: 29337047
J Clin Invest. 2017 Oct 2;127(10):3609-3623
pubmed: 28846070
Immunity. 2011 Apr 22;34(4):492-504
pubmed: 21497118
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14145-50
pubmed: 14610278
Front Immunol. 2018 Jun 18;9:1381
pubmed: 29967616
Curr Biol. 2018 May 7;28(9):1460-1466.e4
pubmed: 29706510
Science. 2012 Jan 27;335(6067):475-9
pubmed: 22282815
Cell. 2008 Feb 22;132(4):583-97
pubmed: 18295577
J Immunol Methods. 2012 May 31;379(1-2):1-14
pubmed: 22370428
Front Immunol. 2019 Feb 19;10:230
pubmed: 30842771
J Exp Med. 1995 Feb 1;181(2):577-84
pubmed: 7836913
Nat Rev Immunol. 2014 Oct;14(10):711
pubmed: 25212742
J Immunol Methods. 2019 Sep;472:35-43
pubmed: 31201792
J Exp Med. 1991 May 1;173(5):1099-109
pubmed: 2022921
J Immunol Methods. 2015 Aug;423:1-2
pubmed: 26229043
JCI Insight. 2018 Nov 15;3(22):
pubmed: 30429372
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nat Immunol. 2003 Nov;4(11):1111-20
pubmed: 14566336
Trends Immunol. 2015 Nov;36(11):670-683
pubmed: 26474675
Front Immunol. 2016 Apr 05;7:119
pubmed: 27092139
Science. 2013 May 3;340(6132):635-9
pubmed: 23493421
Curr Biol. 2001 May 1;11(9):644-51
pubmed: 11369227
J Immunol. 2013 Aug 15;191(4):1578-85
pubmed: 23836060
Science. 2013 May 3;340(6132):630-5
pubmed: 23493420
Nat Immunol. 2016 Jun;17(6):704-11
pubmed: 27064374
Cytometry A. 2011 Jul;79(7):496-506
pubmed: 21638766
Nature. 2016 Apr 21;532(7599):389-93
pubmed: 27064903
Front Immunol. 2014 Feb 03;5:26
pubmed: 24550912
Nat Rev Immunol. 2010 Sep;10(9):621-31
pubmed: 20689559
J Dev Biol. 2015 Dec;3(4):129-157
pubmed: 26844213
Semin Immunol. 2016 Oct;28(5):525-534
pubmed: 27771141
Immunity. 2012 Jan 27;36(1):142-52
pubmed: 22265676
Immunity. 2010 Sep 24;33(3):412-23
pubmed: 20850354
Annu Rev Immunol. 2016 May 20;34:65-92
pubmed: 26666651
J Exp Med. 2007 Oct 29;204(11):2667-77
pubmed: 17954566
J Cell Biol. 2010 Feb 22;188(4):547-63
pubmed: 20156964
Biosci Biotechnol Biochem. 1996 Oct;60(10):1729-31
pubmed: 8987677
Cell Rep. 2015 Jun 9;11(9):1474-85
pubmed: 26027932
Trends Immunol. 2014 Apr;35(4):170-7
pubmed: 24657362
Nat Immunol. 2014 Apr;15(4):365-372
pubmed: 24584088
Immunity. 2016 Feb 16;44(2):233-45
pubmed: 26872694
Front Immunol. 2017 Apr 18;8:426
pubmed: 28458669

Auteurs

Fanny Lafouresse (F)

INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, Toulouse, France.

Romain Jugele (R)

INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, Toulouse, France.

Sabina Müller (S)

INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, Toulouse, France.

Marine Doineau (M)

Toulouse School of Economics, CNRS UMR 5314, Université Toulouse 1 Capitole, France and Institut Universitaire de France, Toulouse, France.

Valérie Duplan-Eche (V)

INSERM, UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France.

Eric Espinosa (E)

INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, Toulouse, France.

Marie-Pierre Puisségur (MP)

INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, Toulouse, France.

Sébastien Gadat (S)

Toulouse School of Economics, CNRS UMR 5314, Université Toulouse 1 Capitole, France and Institut Universitaire de France, Toulouse, France.

Salvatore Valitutti (S)

INSERM U1037, Centre de Recherche en Cancérologie de Toulouse (CRCT), Université de Toulouse III-Paul Sabatier, Toulouse, France.
Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH